Life Sciences

The acquisition is expected to boost Teleflex's global footprint in the peripheral intervention market.

The AI-based early warning system the NHS is developing is part of the government's 10 Year Health Plan to use data to identify patient safety concerns.

The sale drew mixed reactions, with some U.S. states supporting it as a privacy measure and others objecting over legal and data concerns.

The alliance merges DarioHealth's cardiometabolic and behavioral AI-powered health offering with GreenKey's system for managing obstructive sleep apnea.  

Cirrus uses fMRI imaging to acquire and generate maps of critical brain networks to assist with brain surgery planning.  

The announcement comes the same week the pharma giant ended its collaboration with Hims & Hers to sell Wegovy, alleging the company engages in deceptive marketing and illegally sells copycat drugs.

The company offers an AI-enabled workflow automation platform for administrative tasks pertaining to specialty medications. 

The partnership has been terminated less than two months after launch as Novo Nordisk alleges Hims & Hers is illegally selling copycat drugs and using deceptive marketing practices.

Patients will get same-day delivery and access to treatments like GLP-1s and hormone therapies.   

Julien Payen, cofounder and CEO of Lattice Medical, discusses the company’s 3D-printed breast implant that supports women recovering from mastectomy using a scaffold that gradually dissolves as the patient’s own tissue regenerates.